One theory is that sphingolipids generated from sequential ceramide glycosylation activate cSrc and β-linked protein signaling, thereby upregulating METTL3 and mutant p53 R273H protein expression that promote tumor drug resistance [68]. The gene discussed is METTL3; the disease is neoplasm.